Comparing the current results to its competitors, Accelerate Diagnostics Inc reported Revenue decrease in the 4 quarter 2024 year on year by -6.97 %, despite the revenue increase by the most of its competitors of 76.9 %, recorded in the same quarter.
Accelerate Diagnostics Inc , slower than the average decrease reported by the company's competitors of -16.71 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -16.71 %
Accelerate Diagnostics Inc 's Comment on Competition and Industry Peers
The automated microbiological testing market includes key companies such as BD, bioMerieux, Danaher, and TREK, which offer products that require purified bacterial strains or isolates and typically involve at least overnight culturing. T2 Biosystems provides automated bacterial identification products but does not offer rapid antimicrobial susceptibility testing (AST). Potential competitors in rapid AST include Quantamatrix, Q-Linea, Specific Diagnostics, Lifescale, and Gradientech, with several having received FDA marketing authorization. In 2022, bioMerieux acquired Specific Diagnostics for over $400 million, reflecting increased competition in rapid AST testing. The industry experiences rapid technological advancements, frequent new product launches, and numerous acquisitions and licensing agreements.
Reflect Scientific Inc is a company that primarily focuses on developing and manufacturing environmentally friendly cooling and freezing technologies using its proprietary technology. They aim to provide innovative and efficient solutions for industries such as biotechnology, pharmaceuticals, healthcare, and transportation.
Talis Biomedical Corporation operates using a business model centered around developing and commercializing innovative diagnostic tools for infectious disease testing. They aim to provide rapid and accurate testing solutions that can be easily deployed across various healthcare settings to improve patient outcomes.
Danaher Corporation operates a diversified business model centered on developing advanced technologies and solutions across multiple sectors, particularly life sciences, diagnostics, dental, and environmental. The company emphasizes continuous innovation and operational excellence, leveraging its proprietary technologies to drive growth and improve efficiency. By strategically acquiring and integrating complementary businesses, Danaher enhances its product offerings while expanding its global market presence.
Hologic Incs business model focuses on developing and commercializing medical technologies and diagnostic products, primarily dedicated to womens healthcare. Their offerings include innovative solutions for breast and skeletal health, gynecological health, and surgical products, aiming to improve patient outcomes and enhance healthcare practices.
Sources:
Accelerate Diagnostics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Accelerate Diagnostics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
